Compare ALEMBIC with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs DR. DATSONS LABS - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC DR. DATSONS LABS ALEMBIC/
DR. DATSONS LABS
 
P/E (TTM) x 71.7 -10.9 - View Chart
P/BV x 6.2 0.2 3,805.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC   DR. DATSONS LABS
EQUITY SHARE DATA
    ALEMBIC
Mar-18
DR. DATSONS LABS
Mar-14
ALEMBIC/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs72126 57.3%   
Low Rs3431 109.7%   
Sales per share (Unadj.) Rs4.7133.0 3.5%  
Earnings per share (Unadj.) Rs6.10.2 4,025.8%  
Cash flow per share (Unadj.) Rs6.26.6 94.5%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.7128.8 31.6%  
Shares outstanding (eoy) m267.0331.66 843.4%   
Bonus / Rights / Conversions -FCCB-  
Price / Sales ratio x11.30.6 1,914.5%   
Avg P/E ratio x8.7516.1 1.7%  
P/CF ratio (eoy) x8.511.8 71.6%  
Price / Book Value ratio x1.30.6 214.3%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1392,477 570.7%   
No. of employees `000NANA-   
Total wages/salary Rs m20756 370.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2554,211 29.8%  
Other income Rs m37079 470.4%   
Total revenues Rs m1,6254,289 37.9%   
Gross profit Rs m111569 19.5%  
Depreciation Rs m38204 18.5%   
Interest Rs m2430 0.4%   
Profit before tax Rs m44213 3,478.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,212-2 -67,333.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m246 392.6%   
Profit after tax Rs m1,6305 33,955.2%  
Gross profit margin %8.913.5 65.5%  
Effective tax rate %5.448.0 11.3%   
Net profit margin %129.80.1 113,900.9%  
BALANCE SHEET DATA
Current assets Rs m1,8676,852 27.3%   
Current liabilities Rs m5916,711 8.8%   
Net working cap to sales %101.63.3 3,035.4%  
Current ratio x3.21.0 309.3%  
Inventory Days Days94161 58.6%  
Debtors Days Days74318 23.1%  
Net fixed assets Rs m1,7913,673 48.8%   
Share capital Rs m534317 168.7%   
"Free" reserves Rs m10,3243,761 274.5%   
Net worth Rs m10,8584,078 266.3%   
Long term debt Rs m411,671 2.5%   
Total assets Rs m11,59112,633 91.8%  
Interest coverage x260.91.0 25,340.2%   
Debt to equity ratio x00.4 0.9%  
Sales to assets ratio x0.10.3 32.5%   
Return on assets %14.13.4 408.8%  
Return on equity %15.00.1 12,751.5%  
Return on capital %15.27.7 197.9%  
Exports to sales %1.522.9 6.8%   
Imports to sales %21.014.3 146.8%   
Exports (fob) Rs m19964 2.0%   
Imports (cif) Rs m263602 43.8%   
Fx inflow Rs m19964 2.0%   
Fx outflow Rs m264607 43.5%   
Net fx Rs m-244357 -68.5%   
CASH FLOW
From Operations Rs m2361,345 17.5%  
From Investments Rs m-224-2,256 9.9%  
From Financial Activity Rs m-27-1,200 2.2%  
Net Cashflow Rs m-15-2,111 0.7%  

Share Holding

Indian Promoters % 64.0 4.5 1,412.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 1.4 718.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 94.1 27.7%  
Shareholders   54,701 20,807 262.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   NEULAND LABS  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 18, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS